Psychedelic therapies are receiving increasing attention in both the mainstream media and in state and federal policymaking. In this rapidly changing legislative and healthcare context, important questions remain about how to target, scale, and study such therapies.

What is the history and state of psychedelic healthcare in Idaho? What’s on the horizon?

Join us for a conversation with Elizabeth Khan of GLOW (Guiding Legislation on Wellness) and Boise attorney Brian Ertz about the science, policy, and people involved in and informing this evolving field in wellness. We’ll explore the current regulatory landscape, developments across the country, and what they could mean for Idaho. The presentation will also discuss proposed Idaho legislation and the goals behind it, including research, safety, and potential access. Together, we’ll consider the opportunities, challenges, and questions facing Idaho as communities and policymakers navigate the future of psychedelic medicine, with time for audience questions.